B. Cholerton

M. Dorschner, T. Bird, I. Mata, 2016, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised.

I. Mata, M. H. Chagas, C. Zabetian, 2015, Arquivos de neuro-psiquiatria.

Homocysteine and cognitive function in Parkinson's disease.

T. Montine, J. Quinn, J. Leverenz, 2017, Parkinsonism & related disorders.

Statin Users Without an APOE- ε 4 Allele have Increased Insulin Resistance

M. Reger, S. Craft, B. Cholerton, 2011 .

Effects of β-hydroxybutyrate on cognition in memory-impaired adults

M. Reger, S. Craft, C. Hale, 2004, Neurobiology of Aging.

P1-056 Hyperinsulinemia predicts cognitive performance for normal older adults and for patients with Alzheimer's disease

M. Reger, S. Craft, B. Cholerton, 2004, Neurobiology of Aging.

P1-255 Cortisol infusion attenuates insulin's facilitation of verbal memory in patients with Alzheimer's disease

M. Reger, S. Asthana, E. Peskind, 2004, Neurobiology of Aging.

Concepts for brain aging: resistance, resilience, reserve, and compensation

T. Montine, L. Hemmy, C. Kawas, 2019, Alzheimer's Research & Therapy.

Association of Cognition and Dementia With Neuropathologic Changes of Alzheimer Disease and Other Conditions in the Oldest Old

T. Montine, C. Kawas, M. Corrada, 2022, Neurology.

P3-012 Effects of rosiglitazone treatment on serum amyloid-beta 1–40 and 1–42 in patients with early Alzheimer's disease

S. Asthana, S. Plymate, S. Craft, 2004, Neurobiology of Aging.

Insulin and sex interactions in older adults with mild cognitive impairment.

Emily H. Trittschuh, P. Crane, E. Larson, 2012, Journal of Alzheimer's disease : JAD.

Effects of varying diagnostic criteria on prevalence of mild cognitive impairment in a community based sample.

Emily H. Trittschuh, P. Crane, E. Larson, 2011, Journal of Alzheimer's disease : JAD.

Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.

K. Cain, P. Auinger, Changqin Liu, 2014, The American journal of pathology.

Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype

G. Schellenberg, M. Reger, S. Craft, 2006, Neurobiology of Aging.

Effects of aerobic exercise on mild cognitive impairment: a controlled trial.

Glen E Duncan, Suzanne Craft, A. McTiernan, 2010, Archives of neurology.

Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.

M. Reger, S. Asthana, S. Plymate, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Intranasal insulin improves cognition and modulates β-amyloid in early AD

P. Mehta, S. Plymate, S. Craft, 2008, Neurology.

Intranasal insulin improves cognition and modulates beta-amyloid in early AD.

M. Reger, P. Mehta, S. Plymate, 2008, Neurology.

Clinical-pathologic correlations in vascular cognitive impairment and dementia.

T. Montine, P. Crane, E. Larson, 2016, Biochimica et biophysica acta.

Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia.

Emily H. Trittschuh, S. Craft, B. Cholerton, 2015, Journal of Alzheimer's disease : JAD.

Insulin and Alzheimer's disease: untangling the web.

S. Craft, B. Cholerton, L. Baker, 2012, Journal of Alzheimer's disease : JAD.

Follow-up evaluation of cognitive function in the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial and its Follow-up Study

P. Zandi, C. Lyketsos, Denis A. Evans, 2015, Alzheimer's & Dementia.

GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease

M. Albert, T. Montine, J. Trojanowski, 2016, Movement disorders : official journal of the Movement Disorder Society.

The RAB39B p.G192R mutation causes X-linked dominant Parkinson’s disease

M. Dorschner, A. Samii, S. Factor, 2015, Molecular Neurodegeneration.

Title The RAB 39 B p . G 192 R mutation causes X-linked dominant Parkinson ' s disease Permalink

M. Dorschner, A. Samii, S. Factor, 2015 .

Insulin, cognition, and dementia.

S. Craft, B. Cholerton, L. Baker, 2013, European journal of pharmacology.

O3-05-05 Therapeutic effects of daily intranasal insulin administration in early Alzheimer’s disease

M. Reger, S. Craft, J. Breitner, 2006, Alzheimer's & Dementia.

Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach

T. Montine, S. Craft, B. Cholerton, 2016, Diabetes Spectrum.

The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot

M. Dorschner, T. Bird, I. Mata, 2017, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.

G. Schellenberg, M. Reger, S. Plymate, 2008, Journal of Alzheimer's disease : JAD.

Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau.

L. Tian, T. Montine, J. Quinn, 2020, Brain : a journal of neurology.

CSF sTREM2 correlates with CSF tau in advancing Parkinson’s disease

L. Tian, T. Montine, J. Quinn, 2019, bioRxiv.

Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone: A Preliminary Study

M. Reger, S. Asthana, S. Plymate, 2005 .

Statin users without an APOE-epsilon4 allele have increased insulin resistance.

M. Reger, S. Plymate, S. Craft, 2010, Journal of Alzheimer's disease : JAD.

Estrogen and Alzheimer’s Disease

Sanjay Asthana, S. Asthana, B. Cholerton, 2002, Drugs & aging.

Insulin resistance and pathological brain ageing

S. Craft, B. Cholerton, L. Baker, 2011, Diabetic medicine : a journal of the British Diabetic Association.

Review Article Insulin resistance and pathological brain ageing

S. Craft, B. Cholerton, L. Baker, 2011 .

Associations between Use of Specific Analgesics and Concentrations of Amyloid-β 42 or Phospho-Tau in Regions of Human Cerebral Cortex.

T. Montine, P. Crane, E. Larson, 2018, Journal of Alzheimer's disease : JAD.

The associations among sociocultural factors and neuropsychological functioning in older American Indians: The Strong Heart Study.

T. Montine, S. Verney, W. Longstreth, 2019, Neuropsychology.

Type 2 diabetes and later cognitive function in older American Indians: The Strong Heart Study

T. Montine, B. Howard, S. Verney, 2019, International journal of geriatric psychiatry.

Total Brain and Hippocampal Volumes and Cognition in Older American Indians: The Strong Heart Study

T. Montine, T. Grabowski, B. Howard, 2017, Alzheimer disease and associated disorders.

Concepts for brain aging: resistance, resilience, reserve, and compensation

T. Montine, L. Hemmy, C. Kawas, 2019, Alzheimer's Research & Therapy.

Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.

M. Albert, T. Montine, J. Trojanowski, 2016, JAMA neurology.

Cognitive associations with comprehensive gait and static balance measures in Parkinson's disease.

Thomas J. Grabowski, Thomas J. Montine, Valerie E. Kelly, 2019, Parkinsonism & related disorders.

Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease.

F B Horak, F. Horak, T. Montine, 2015, Parkinsonism & related disorders.

Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease.

Glen E Duncan, Suzanne Craft, A. McTiernan, 2010, Journal of Alzheimer's disease : JAD.

Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease.

M. Albert, T. Montine, J. Quinn, 2018, Parkinsonism & related disorders.

Effects of insulin and octreotide on memory and growth hormone in Alzheimer's disease.

G. Schellenberg, S. Asthana, S. Craft, 2009, Journal of Alzheimer's disease : JAD.

Using Varying Diagnostic Criteria to Examine Mild Cognitive Impairment Prevalence and Predict Dementia Incidence in a Community-Based Sample.

Emily H. Trittschuh, P. Crane, E. Larson, 2019, Journal of Alzheimer's disease : JAD.

Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale‐2 in Parkinson's disease

T. Montine, J. Quinn, K. Poston, 2018, Movement disorders : official journal of the Movement Disorder Society.

APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.

T. Montine, J. Trojanowski, J. Quinn, 2014, JAMA neurology.

Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures

T. Montine, J. Quinn, J. Leverenz, 2019, Clinical parkinsonism & related disorders.

An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele

L. Tian, V. Henderson, K. Poston, 2019, Neurobiology of Disease.

Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson’s disease

L. Tian, T. Montine, J. Quinn, 2019, Journal of clinical and experimental neuropsychology.

Cognitive response to estradiol in postmenopausal women is modified by high cortisol

P. Mehta, S. Asthana, S. Plymate, 2012, Neurobiology of Aging.

Prediction of neuropathologic lesions from clinical data

N. Aghaeepour, T. Montine, G. Beecham, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Semantic fluency and processing speed are reduced in non-cognitively impaired participants with Parkinson’s disease

T. Montine, J. Quinn, T. Dawson, 2021, Journal of clinical and experimental neuropsychology.

Multivariate prediction of dementia in Parkinson’s disease

L. Tian, N. Aghaeepour, T. Montine, 2020, npj Parkinson's Disease.

Participant and Study Partner Reported Impact of Cognition on Functional Activities in Parkinson's Disease

L. Tian, T. Montine, J. Quinn, 2020, Movement disorders clinical practice.

High-intensity physical activity modulates diet effects on cerebrospinal amyloid-β levels in normal aging and mild cognitive impairment.

T. Montine, S. Craft, N. Postupna, 2012, Journal of Alzheimer's disease : JAD.

Neuropsychologic assessment in collaborative Parkinson’s disease research: A proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson’s Disease Research at the University of Pennsylvania and the University of Washington

T. Montine, J. Trojanowski, A. Siderowf, 2013, Alzheimer's & Dementia.

Relationship between Sensorimotor Inhibition and Mobility in Older Adults with and without Parkinson's Disease.

Douglas N. Martini, F. Horak, T. Montine, 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.

Erratum to: The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot (American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, (2016), 171, 7, (925-930), 10.1002/ajmg.b.32452)

M. Dorschner, T. Bird, I. Mata, 2017 .

Cognitive Correlates of MRI-defined Cerebral Vascular Injury and Atrophy in Elderly American Indians: The Strong Heart Study

T. Montine, S. Verney, W. Longstreth, 2019, Journal of the International Neuropsychological Society.

Cognitive profile of LRRK2‐related Parkinson's disease

T. Montine, J. Trojanowski, D. Dickson, 2015, Movement disorders : official journal of the Movement Disorder Society.

Illusory Responses across the Lewy Body Disease Spectrum

T. Montine, K. Poston, B. Cholerton, 2022, Annals of neurology.

People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance

Beate Ritz, Daniel Weintraub, James B Leverenz, 2014, Movement disorders : official journal of the Movement Disorder Society.

Evaluation of mild cognitive impairment subtypes in Parkinson's disease

T. Montine, J. Quinn, A. Espay, 2014, Movement disorders : official journal of the Movement Disorder Society.

O4-05-05 Rosiglitazone preserves cognitive functions in patients with early Alzheimer's disease

M. Reger, S. Asthana, S. Craft, 2004, Neurobiology of Aging.

TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study.

T. Montine, L. Hemmy, S. Edland, 2018, Journal of Alzheimer's disease : JAD.

Associations between baseline cognitive status and motor outcomes after treadmill training in people with Parkinson's disease: a pilot study.

V. E. Kelly, C. Zabetian, B. Cholerton, 2023, Disability and rehabilitation.

Neuropathologic correlates of cognition in a population-based sample.

T. Montine, P. Crane, E. Larson, 2013, Journal of Alzheimer's disease : JAD.

Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease

T. Montine, J. Trojanowski, J. Quinn, 2017, Neurobiology of Aging.

Resting-State Cerebello-Cortical Dysfunction in Parkinson's Disease

T. Montine, T. Grabowski, C. Zabetian, 2021, Frontiers in Neurology.

Cognition as a mediator for gait and balance impairments in GBA-related Parkinson’s disease

Douglas N. Martini, F. Horak, T. Montine, 2022, npj Parkinson's Disease.

Cognition as a mediator for gait and balance impairments in GBA-related Parkinson’s disease

Douglas N. Martini, F. Horak, T. Montine, 2022, npj Parkinson's Disease.

Gait and balance in apolipoprotein Ɛ4 allele carriers in older adults and Parkinson’s disease

Douglas N. Martini, F. Horak, T. Montine, 2023, Clinical parkinsonism & related disorders.

Hallucinations and Development of Dementia in Parkinson's Disease.

T. Montine, J. Trojanowski, J. Quinn, 2020, Journal of Parkinson's disease.

Arterial spin labeling detects perfusion patterns related to motor symptoms in Parkinson's disease.

T. Montine, T. Grabowski, C. Zabetian, 2020, Parkinsonism & related disorders.

Precision Medicine: Clarity for the Complexity of Dementia.

T. Montine, T. Grabowski, J. Quinn, 2016, The American journal of pathology.

Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease

Mark A. Reger, Sanjay Asthana, Lutz Frölich, 2006, Neurobiology of Aging.

Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment.

Emily H. Trittschuh, M. Donohue, S. Moghadam, 2015, Journal of Alzheimer's disease : JAD.

Therapeutic effects of long-acting intranasal insulin detemir for Alzheimer's dementia or mild cognitive impairment

Emily H. Trittschuh, S. Craft, B. Cholerton, 2013, Alzheimer's & Dementia.

Long-acting intranasal insulin detemir improves working memory for adults with mild cognitive impairment or early-stage Alzheimer's dementia

Emily H. Trittschuh, S. Craft, B. Cholerton, 2013, Alzheimer's & Dementia.

Neuroprotective effects of female sex steroids in humans: current controversies and future directions.

Sterling C. Johnson, S. Asthana, S. Johnson, 2005, Cellular and molecular life sciences : CMLS.

Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.

C. Kawas, M. Corrada, L. White, 2023, Journal of Alzheimer's disease : JAD.

Aerobic exercise effects on cognition in at-risk adults: Role of insulin sensitivity and APOE-ε4

J. Williamson, K. Sink, A. McTiernan, 2013, Alzheimer's & Dementia.

O2-02-06 Insulin effects on plasma beta-amyloid levels in normal adults and patients with AD

S. Asthana, S. Plymate, S. Craft, 2004, Neurobiology of Aging.

Effects of aerobic exercise on mild cognitive impairment: a controlled trial.

A. McTiernan, P. Mehta, S. Plymate, 2010, Archives of neurology.

Intranasal insulin improves cognition and modulates β-amyloid in early AD

P. Mehta, S. Plymate, S. Craft, 2008, Neurology.

Follow-up evaluation of cognitive function in the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial and its Follow-up Study

P. Zandi, C. Lyketsos, Denis A. Evans, 2015, Alzheimer's & Dementia.

GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease

M. Albert, T. Montine, J. Trojanowski, 2016, Movement disorders : official journal of the Movement Disorder Society.

Precision Medicine: Clarity for the Complexity of Dementia.

K. Montine, C. Zabetian, B. Cholerton, 2016, The American journal of pathology.

Quantitative estimate of cognitive resilience and its medical and genetic associations

N. Aghaeepour, T. Phongpreecha, A. Chang, 2023, Alzheimer's Research & Therapy.

APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.

T. Montine, J. Trojanowski, J. Quinn, 2014, JAMA Neurology.

Neuropathologic Burden and Dementia in Nonagenarians and Centenarians.

M. Corrada, Caitlin S. Latimer, B. Cholerton, 2024, Neurology.

Clinical-pathologic correlations in vascular cognitive impairment and dementia.

Caitlin S. Latimer, K. Montine, B. Cholerton, 2016, Biochimica et biophysica acta.